Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Reach - Recruits another 400 writers

January 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • RCH
  • Price:
  • 285p
Revenues are ahead of expectations in H2 to date with Print -3.5% and digital +17.2% versus Singer Capital Markets’ expectations for -8.9% and +12.8%, respectively. That meant overall sales rose 1.2%, a huge improvement on the 11.9% decline since 2019, with digital up a staggering 39% on a two year basis. Rather excitingly, Reach increased customer registrations from 6.7m to over 8m and if this run rate is sustained it could hit 12 million by end 2022 (thrashing its 10m target).The strong performance was partly driven by stabilised print advertising and circulation but mainly better yields from digital advertising as better targeted audience data improved return on investment for advertisers. As Singer says, “Continued ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X